Schedule of Incurred Expenses of Minority Shareholders (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Cost of Revenue
Cost of Revenue	$ 1,626	$ 144	$ 1,996	$ 144
Research and Development Expense
Total Related Party Expenses	350	439	1,230	988
General and Administrative Expense [Member]
General and Administrative Expense
Amended CWRU License Agreement - reimbursement of patent legal fees		10		10
Stock-based compensation expense – Physician Inventors’ stock options	275	273	819	637
Research and Development Expense [Member]
General and Administrative Expense
Amended CWRU License Agreement - reimbursement of patent legal fees		82	209	195
Stock-based compensation expense – Physician Inventors’ stock options	52	56	151	114
Research and Development Expense
Fees - Physician Inventors’ consulting agreements	15	8	32	22
Sponsored research agreement	4		6
Royalty [Member]
Cost of Revenue
Cost of Revenue	$ 4	$ 10	$ 13	$ 10